What role do drug transporters play in pharmacogenomics?

Question

BlackTom AI · Accepted Answer

To understand the question, we start by identifying what drug transporters do in the context of pharmacogenomics.
Option 1 suggests that transporters change the genetic code to better suit drug therapy. In reality, transporters do not alter DNA sequences or gene coding; their role is functional, affecting how drugs are moved across cellular membranes, not genetic material itself.
Option 2 states that transporters influence drug absorption, distribution, metabolism, and excretion (ADME). This aligns with established pharmacokinetic principles: transporters can affect how drugs enter cells (absorption), how they reach target tissues or are distributed within the body, how they interact with metabolic enzymes and other pathways, and how they are eliminated (excretion).
Option 3 claims transporters increase the immunogenicity of a drug. Immunogenicity relates to immune recognition and antigenicity, not the transport of drugs across membranes; transporter activity is not a primary driver of a drug’s immunogenic potential.
Option 4 asserts transporters alter the pH levels in the stomach to improve drug solubility. Transporters do not regulate gastric pH; acid-base balance in the stomach is governed by other physiological processes and secretions, not transporter function.
Overall, the most accurate characterization is that drug transporters modulate the ADME processes, impacting how drugs are absorbed, distributed, metabolized, and excreted, which has direct implications for pharmacogenomics and individual variability in drug response.

What role do drug transporters play in pharmacogenomics?单项选择题

类似问题

Evaluate the implications of pharmacogenomic variations in metabolizing enzymes when designing a clinical trial for a new cardiovascular drug.

How can genetic variation in HLA antigens influence drug therapy outcomes?

When considering the variability of drug metabolism among different geographical ancestries, which factor is most relevant for optimizing patient-specific therapy?

In evaluating a patient’s CYP2D6 phenotype before prescribing a drug with a narrow therapeutic window, which of the following represents the most critical clinical concerns?

Which factor is NOT typically influenced by genetic variations in pharmacogenomics?

Evaluate the importance of integrating pharmacogenomic considerations into global drug development strategies.

How did Egyptian culture and governance change during the Ptolemaic period compared to the pharaonic period?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单